Atlas Trials

The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV

Clinical trial NCT05690802 · RECRUITING

Trial details

NCT number
NCT05690802
Sponsor
Xijing Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Nausea and Vomiting
Start date
2022-05-16
Primary completion
2027-05-30
Enrollment
1060

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.